Page 7 - Complete Response News Today

Since the beginning of the COVID-19 pandemic, the US Food and Drug Administration (FDA or the Agency) has issued more than 80 guidance documents describing flexibilities that would be available...

– Achieved significant clinical progress for UltraCAR-T® and AdenoVerse™ investigational therapeutics in 2022 – – Presented positive clinical data for...

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase...

Alvotech is a biosimilar manufacturer that joined the Nasdaq in June. Read why I think success isn't guaranteed for ALVO stock.

Immuneel Therapeutics presents early data from India for Varnimcabtagene autoleucel at ASH Annual Meeting 2022, USA

/PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that...

Complete responses were observed in patients who received at least three previous lines of treatment Recent clinical data add to the growing enthusiasm for the therapeutic potential of cancer... | December 15, 2022

– Single infusion of UltraCAR-T cells with or without lymphodepletion demonstrated robust expansion and persistence in blood and bone marrow – – PRGN-3006...

RVU120 Demonstrates Single-Agent Activity with a Complete Response, 4 Blast Reductions, and 4 Erythroid and/or Platelet responses in Patients with...

Special Note Regarding Forward-Looking Statements Certain statements in this Report contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of... | November 14, 2022